Sort
10,766 grants matching “checkpoint inhibitor”
Immune Monitoring and Flow Cytometry (IMFC)
$5,263Jacqueline Yvonne Channon Smith · Dartmouth College · P30 · FY2024 · CA
Program 30: Neuro-Oncology
$5,123Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Program 4: Leukemia
$5,123Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$5,037Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
FASEB SRC on Autoimmunity
$5,000Alessandra B Pernis · Federation Of Amer Soc For Exper Biology · R13 · FY2019 · AI
AACR Special Conference on Endometrial Cancer: New Biology Driving Research and Treatment
$5,000Margaret Foti · American Association For Cancer Research · R13 · FY2020 · CA
Cancer Evolution and Combinatorial Cancer Therapies: Concepts and Challenges
$5,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2020 · CA
Annual International Primary CNS Lymphoma Collaborative Group Meeting
$5,000Tracy T Batchelor · Massachusetts General Hospital · R13 · FY2019 · CA
Gastrointestinal Cancer Research Program (GI) (Project-005)
$4,817Jordan D Berlin · Vanderbilt University Medical Center · P30 · FY2018 · CA
Gastrointestinal Cancer Research Program (GI) (Project-005)
$4,735Jordan D Berlin · Vanderbilt University Medical Center · P30 · FY2018 · CA
Immunology
$4,496Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2020 · CA
A polymorphism in the Mdm2 promoter enhances cancer risk
$4,337Sean M Post · University Of Tx Md Anderson Can Ctr · F32 · FY2007 · CA
Mechanisms of Macrophage-Mediated Tumor Metastasis
$4,202Lauren E Burkard · State University Of New York At Buffalo · F30 · FY2016 · CA
PD-1 Blockade and Neoantigen-Specific T Cell Immunity
$4,095Gerald P Linette · Washington University · R21 · FY2016 · CA
The Role of Checkpoint inhibitors in CIA
$4,082Megan Kay Wood · Johns Hopkins University · F31 · FY2022 · AR
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$4,029Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Program 4: Leukemia
$3,833Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Program 30: Neuro-Oncology
$3,833Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Immunology
$3,751Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2018 · CA
CV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
$3,513Arun Rajan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Signaling and Biotechology Program
$3,396Hui-Kuan Lin · Wake Forest University Health Sciences · P30 · FY2019 · CA
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
$3,363Y. Alan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA
$3,309Marietta Y. Lee · University Of Washington · P41 · FY2009 · RR
SPINDLE CHECKPOINT SIGNALING
$3,309Kevin S Hardwick · University Of Washington · P41 · FY2009 · RR
Immunology
$3,288Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2018 · CA